Phase Ⅱ Study of Adductor Canal Block With HR18034 for Postsurgical Pain Management

NCT05561309 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

89

Enrollment

INDUSTRY

Sponsor class

Conditions

Total Knee Arthroplasty

Interventions

DRUG: HR18034;Ropivacaine Hydrochloride Injection

Sponsor

Shanghai Hengrui Pharmaceutical Co., Ltd.